RACHEL GERSHENSON: Open Payments
NPI 1629604152 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 10 payments from 8 companies in 2025. Trend: 2023 $397 · 2024 $543 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $75 |
| SOBI, INC | 1 | $42 |
| Teleflex LLC | 1 | $39 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| Celgene Corporation | 1 | $31 |
| Syndax Pharmaceuticals, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $29 |
Products named: JAYPIRCA, REBLOZYL, Vonjo, ARROW, INQOVI, JAKAFI.
Industry payments across TX — which companies pay providers there.
